Skip to main content
. 2017 Mar 9;8(15):25455–25468. doi: 10.18632/oncotarget.16037

Figure 1. Correlation between time to first therapy (TTFT) and genetic abnormalities.

Figure 1

(A) TTFT stratified according to the FISH abnormlities. (B) TTFT stratified according to the IGHV mutation status.